drugset / Trial / NCT02043821
Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker
RandomizedParallel-groupTriple-blindTreatment
Summary
Colorectal cancer patients with metastases (mCRC) at response under first-line chemotherapy are candidates for an convenient maintenance treatment.
Timeline
- Start
- —
- Primary completion
- 2016-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1250 mg/m2 | Oral |